Home/Filings/4/0001209191-24-003090
4//SEC Filing

THERO JOHN F 4

Accession 0001209191-24-003090

CIK 0001662244other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:00 PM ET

Size

6.9 KB

Accession

0001209191-24-003090

Insider Transaction Report

Form 4
Period: 2024-02-08
THERO JOHN F
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-08$1.69/sh+12,828$21,67922,828 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-0812,8280 total
    Exercise: $1.69From: 2024-02-03Exp: 2033-02-03Common Stock (12,828 underlying)

Issuer

Cyteir Therapeutics, Inc.

CIK 0001662244

Entity typeother

Related Parties

1
  • filerCIK 0001199637

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:00 PM ET
Size
6.9 KB